FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045305706> ?p ?o ?g. }

• W2045305706 endingPage "399" @default.
• W2045305706 startingPage "397" @default.
• W2045305706 abstract "examinations. They reported a higher proportion of clinically unsuspected relapses (58 of 84), but defined relapse to include M-2. In 50 of the 84 relapses there was less than 25% blasts in the bone marrow. They found no difference, however, in the success of second remission induction or second remission duration, and concluded that bone marrow investigation for detecting early relapse in acute lymphatic leukemia of childhood may be unnecessary. There are two purposes for the performance of studies in patients participating in clinical trials: (1) the benefit of the patient, and (2) to compare treatment regimens accurately. For clinical care, it would appear that the majority of relapses will be suspected on clinical or peripheral blood criteria. At present there are no data to suggest that earlier detection of relapse will change curability. It is also highly unlikely that the performance of bone marrow aspiration at frequent intervals (or any interval) will improve the statistical comparability of treatment plans, because 72% of relapses occurred within one month of finding a previous M-1 bone marrow and were clinically suspected prior to the aspiration. REFERENCES 1. Watson DK, Robinson AE, Bailey CC: A reappraisal of routine marrow examination therapy of acute lymphoblastic leukemia. Arch Dis Child 56:392, 1981. 2. Haworth C, Hippleston AD, Morris-Jones PH, et al: Routine bone marrow examination in the management of acute lymphoblastic leukaemia of childhood. J Clin Pathol 34:483, 198I. 3. Leikin SL, Brubaker C, Hartmann JR, etal : Criteria for chemotherapy in acute leukemia. Cancer 21:349, 1968. 4. Komp DM, George SL, Falletta J, et al: Cyclophosphamideasparaginase-vincristine-prednisone induction therapy in childhood acute lymphocytic and non-lymphocytic leukemia. Cancer 37:1243, 1976. 5. Berry DH, Pullen J, George S, et al: Comparison of prednisone, vincristine, methotrexate and 6-mercaptopurine vs vincristine and prednisone induction therapy in childhood acute leukemia. Cancer 36:98, 1975. 6. Cox DR: Regression models and life tables. J R Stat Soc 34:187, 1972." @default.
• W2045305706 created "2016-06-24" @default.
• W2045305706 creator A5009296124 @default.
• W2045305706 creator A5069229780 @default.
• W2045305706 creator A5077083479 @default.
• W2045305706 creator A5078431306 @default.
• W2045305706 creator A5086684866 @default.
• W2045305706 creator A5090485381 @default.
• W2045305706 date "1983-03-01" @default.
• W2045305706 modified "2023-10-18" @default.
• W2045305706 title "Growth in patients with chronic granulomatous disease" @default.
• W2045305706 cites W1967833122 @default.
• W2045305706 cites W2017925788 @default.
• W2045305706 cites W2121506490 @default.
• W2045305706 cites W2334070453 @default.
• W2045305706 doi "https://doi.org/10.1016/s0022-3476(83)80659-3" @default.
• W2045305706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6827411" @default.
• W2045305706 hasPublicationYear "1983" @default.
• W2045305706 type Work @default.
• W2045305706 sameAs 2045305706 @default.
• W2045305706 citedByCount "16" @default.
• W2045305706 countsByYear W20453057062016 @default.
• W2045305706 countsByYear W20453057062018 @default.
• W2045305706 crossrefType "journal-article" @default.
• W2045305706 hasAuthorship W2045305706A5009296124 @default.
• W2045305706 hasAuthorship W2045305706A5069229780 @default.
• W2045305706 hasAuthorship W2045305706A5077083479 @default.
• W2045305706 hasAuthorship W2045305706A5078431306 @default.
• W2045305706 hasAuthorship W2045305706A5086684866 @default.
• W2045305706 hasAuthorship W2045305706A5090485381 @default.
• W2045305706 hasConcept C126322002 @default.
• W2045305706 hasConcept C16005928 @default.
• W2045305706 hasConcept C177713679 @default.
• W2045305706 hasConcept C203014093 @default.
• W2045305706 hasConcept C2778175462 @default.
• W2045305706 hasConcept C2779134260 @default.
• W2045305706 hasConcept C2987552334 @default.
• W2045305706 hasConcept C3018113122 @default.
• W2045305706 hasConcept C71924100 @default.
• W2045305706 hasConceptScore W2045305706C126322002 @default.
• W2045305706 hasConceptScore W2045305706C16005928 @default.
• W2045305706 hasConceptScore W2045305706C177713679 @default.
• W2045305706 hasConceptScore W2045305706C203014093 @default.
• W2045305706 hasConceptScore W2045305706C2778175462 @default.
• W2045305706 hasConceptScore W2045305706C2779134260 @default.
• W2045305706 hasConceptScore W2045305706C2987552334 @default.
• W2045305706 hasConceptScore W2045305706C3018113122 @default.
• W2045305706 hasConceptScore W2045305706C71924100 @default.
• W2045305706 hasIssue "3" @default.
• W2045305706 hasLocation W20453057061 @default.
• W2045305706 hasLocation W20453057062 @default.
• W2045305706 hasOpenAccess W2045305706 @default.
• W2045305706 hasPrimaryLocation W20453057061 @default.
• W2045305706 hasRelatedWork W14918886 @default.
• W2045305706 hasRelatedWork W2010946112 @default.
• W2045305706 hasRelatedWork W2012704756 @default.
• W2045305706 hasRelatedWork W2113972407 @default.
• W2045305706 hasRelatedWork W2148086742 @default.
• W2045305706 hasRelatedWork W2410113596 @default.
• W2045305706 hasRelatedWork W4242931784 @default.
• W2045305706 hasRelatedWork W4299287234 @default.
• W2045305706 hasRelatedWork W4322724875 @default.
• W2045305706 hasRelatedWork W85654833 @default.
• W2045305706 hasVolume "102" @default.
• W2045305706 isParatext "false" @default.
• W2045305706 isRetracted "false" @default.
• W2045305706 magId "2045305706" @default.
• W2045305706 workType "article" @default.